Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors

Pleural effusion is a rare immune-related adverse event for lung cancer patients receiving immune checkpoint inhibitors (ICIs). We enrolled 281 lung cancer patients treated with ICIs and 17 were analyzed. We categorized the formation of pleural effusion into 3 patterns: type 1, rapid and massive; ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Po-Hsin, Yang, Tsung-Ying, Chen, Kun-Chieh, Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Wu, Yu-Chen, Liu, Ko-Jiunn, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087817/
https://www.ncbi.nlm.nih.gov/pubmed/33931705
http://dx.doi.org/10.1038/s41598-021-89043-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087817/
https://www.ncbi.nlm.nih.gov/pubmed/33931705
http://dx.doi.org/10.1038/s41598-021-89043-4

Ejemplares similares